Navigation Links
Racial disparity in colon cancer survival not easily explained, UAB researchers say
Date:11/23/2009

BIRMINGHAM, Ala. A new study by University of Alabama at Birmingham (UAB) researchers shows that body-mass index (BMI) and co-existing medical conditions (co-morbidity) do not explain the decreased survival observed among African-Americans compared to Caucasians who also have colon cancer. The study is published online Nov. 23 in Cancer, a journal of the American Cancer Society.

The finding indicates that although BMI and co-morbidity are independent predictors of poor survival for all patients, these factors do not explain the increased risk of death associated with African-Americans. "Therefore, more research is needed to gain a fuller understanding of how race and ethnicity are involved in colon cancer survival following surgery," says Upender Manne, Ph.D., an associate professor in the UAB Department of Pathology and the lead study author.

For many cancers, including colon cancer, African-Americans have lower survival rates than whites; possible reasons behind this disparity including genetic variation, tumor characteristics, access to health care and other factors are being examined extensively, Manne says. There was a belief that racial disparity in survival following surgery for colon cancer was related to a high BMI and co-morbidity. BMI is a numerical value of weight in relation to height; obesity is defined as a BMI of 30 or more.

The UAB researchers analyzed data from 496 patients who underwent surgery for colon cancer at UAB Hospital between 1981 and 2002. Until the end of the study in 2008, the researchers looked at factors such as BMI, co-morbidity, demographics and tumor properties as they relate to survival rates.

The analysis revealed that African-Americans were 34 percent more likely to have died by the end of the study than Caucasians. Among patients with advanced stages of cancer, being underweight increased the risk of death by 87 percent. Being overweight or obese was protective in patients with Stage IV disease and decreased the risk of death by 42 percent.

"That was the surprising finding for us that a high BMI was actually protective in patients with advanced-stage disease," Manne says. "Co-morbidity in cancer can have an important role, we know, because it impacts everything from the timing of diagnosis to treatment decisions. Obviously, BMI and co-morbidity are not the answers we need to explain the survival disparity in colon cancer. Something else is going on."


'/>"/>

Contact: Troy Goodman
tdgoodman@uab.edu
205-934-8938
University of Alabama at Birmingham
Source:Eurekalert

Related biology news :

1. Racial disparities in cardiovascular health linked to birth weight, slavery
2. Hypertension disparity linked to environment
3. University of Toronto study shows disparity of effect of climate change on UV radiation
4. Western diet linked to increased risk of colon cancer recurrence
5. Pig study sheds new light on the colonisation of Europe by early farmers
6. Analysis of breast and colon cancer genes finds many areas of differences between tumors
7. Genome update defines landscape of breast and colon cancers
8. $2.7 million awarded for metastatic colon cancer research
9. Colony collapse disorder symposium added to ESA Annual Meeting
10. DNA methylation shown to promote development of colon tumors
11. Vitamin D and calcium influence cell death in the colon, researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/21/2017)... 21, 2017 Der weltweite Biobanking-Sektor ... Nach einem Gespräch mit mehr als 50 Vertretern aus verschiedenen ... überwinden gilt, um diese Prognose zu realisieren. ... Zu ... der finanziellen Mittel für die Biobank, die Implementierung Zeit ...
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... , March 27, 2017 The ... to a comprehensive library of reports on Valero Energy ... transportation fuels and petrochemical industries. ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) ... biofuel production to go green. Ethanol today, even though touted ...
(Date:3/27/2017)... SAN DIEGO , March 27, 2017  Trovagene, ... announced that its Chief Executive Officer, Bill Welch ... on April 4, 2017 at 9:00 AM EDT at ... .  Bill Welch, and Chief Scientific Officer, ... meet with investors during the conference.   The ...
(Date:3/24/2017)... 24, 2017 MiMedx Group, Inc. (NASDAQ: MDXG), ... placental tissue allografts and patent-protected processes to develop and ... healthcare, announced today  that it will present at the ... , NY.  Parker H. "Pete" Petit, Chairman and CEO, ... Christopher M. Cashman , EVP and Chief Commercialization Officer, ...
(Date:3/24/2017)... BEIJING , March 24, 2017 Sinovac Biotech Ltd. ... products in China , today announced that its ... the expiration date of the plan from March 27, 2017 to ... proposal. About Sinovac Biotech Ltd. ... Sinovac Biotech Ltd. is ...
Breaking Biology Technology: